.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Express Scripts
Merck
Cipla
Citi
McKesson
Daiichi Sankyo

Generated: December 17, 2017

DrugPatentWatch Database Preview

ACTIQ Drug Profile

« Back to Dashboard

Which patents cover Actiq, and what generic alternatives are available?

Actiq is a drug marketed by Cephalon and is included in one NDA.

The generic ingredient in ACTIQ is fentanyl citrate. There are thirty-one drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the fentanyl citrate profile page.
Drug patent expirations by year for ACTIQ

Pharmacology for ACTIQ

Drug ClassOpioid Agonist
Mechanism of ActionFull Opioid Agonists

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-001Nov 4, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-004Nov 4, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-002Nov 4, 1998ABRXYesYes► Subscribe► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-003Nov 4, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-006Nov 4, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-005Nov 4, 1998ABRXYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ACTIQ

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-006Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-003Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-005Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-004Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-001Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-003Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-006Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-005Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-003Nov 4, 1998► Subscribe► Subscribe
CephalonACTIQfentanyl citrateTROCHE/LOZENGE;TRANSMUCOSAL020747-002Nov 4, 1998► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for ACTIQ

Drugname Dosage Strength RLD Submissiondate
fentanyl citrateLozenges0.4 mgActiq10/6/2004
fentanyl citrateLozenges0.6 mgActiq12/20/2004
fentanyl citrateLozenges0.8 mg, 1.2 mg and 1.6 mgActiq11/22/2004
fentanyl citrateLozenges0.2 mgActiq10/29/2004

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Daiichi Sankyo
Deloitte
US Department of Justice
Harvard Business School
Queensland Health
Chinese Patent Office
Fuji
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot